This paper reviewed the development of biological holography theory， discussed on the limitations of biological holography law， and explained the theoretical connotation and basis of the “three-level two-node and three-segment holographic theory” innovatively proposed by Academician TONG Xiaolin， aiming at inspiring new thinking on the theoretical research of biological holography. By observing the human body structure， Academician TONG Xiaolin finds that there is a similar law in the head， trunk， limbs， and fingers （toes） that there are two moveable joints （groups） dividing the part into three segments， and each segment contains all the information of the whole part， which is a holographic phenomenon. Accordingly， Academician TONG creatively put forward the “three-level two-node and three-segment holographic theory” of the human body， and “three levels” respectively refer to the original level trunk， the branch level limbs， and the end level extremities. The “two nodes” refer to the two joints （groups） of each level， and “two nodes” can be further divided into “three segments”. Therefore， there are “two nodes” and “three segments” in each level with a similar distribution pattern， which reflects the holographic distribution law that the part reflects the whole and the whole includes the part.

Perimenopausal syndrome （MPS）， a common endocrine system disease， is one of the diseases responding specifically to traditional Chinese medicine （TCM）. The China Association of Chinese Medicine organized experts in endocrinology， gynecology， and interdisciplinary fields of both Western and Chinese medicine to discuss the advantages and challenges of diagnosing and treating MPS with Western medicine， TCM， and integrative medicine. Experts at the conference believe that MPS is initiated by estrogen decline and rooted in deficiency， with the pathogenesis being imbalance between Yin and Yang in the kidney. The hormone replacement therapy in Western medicine for menopause can rapidly alleviate related symptoms by quickly restoring the estrogen level and timely detect and delay complications of menopause， whereas such a therapy has certain risks， necessitating close monitoring of adverse reactions. Moreover， the various contraindications and precautions limit the clinical application of the hormone replacement therapy. TCM has advantages in synergistically alleviating symptoms such as hot flashes， sweating， sleep disorders， and emotional abnormalities of MPS without causing obvious adverse reactions. However， its efficacy is slower than the hormone replacement therapy， and the TCM evidence for preventing and treating complications of menopause remains unclear. Three suggestions were proposed for the future development of both Western and TCM for ameliorating MPS. First， an integrated diagnosis and treatment system for MPS with both Western and Chinese medicine should be established. Second， high-quality evidence-based interventions for MPS should be developed with TCM alone or in combination with Western medicine. Third， efforts should be made to promote the new TCM drug development and the interdisciplinary cooperation for treating MPS.